SIMARD JOHN (Chief Executive Officer) sold 1.2% of their position (48.61K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $624.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/6/2021ACC: 0001209191-21-059849
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-48.61K
Net shares
Net seller
$624.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
48.61K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−23.68K
Price / share
$13.08
Trade value
$309.86K
% of position
0.6%
10/4/2021
4.01M→3.99M
Common Stock
Direct
Shares
−14.22K
Price / share
$12.66
Trade value
$180.06K
% of position
0.4%
10/5/2021
3.99M→3.97M
Common Stock
Direct
Shares
−10.71K
Price / share
$12.53
Trade value
$134.26K
% of position
0.3%
10/6/2021
3.97M→3.96M
Total
Net shares
−48.61K
Net value
-$624.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2021 | S · Sale | −23.68K | $13.08 | $309.86K | 0.6% | 4.01M | 3.99M |
| Common Stock Direct | 10/5/2021 | S · Sale | −14.22K | $12.66 | $180.06K | 0.4% | 3.99M | 3.97M |
| Common Stock Direct | 10/6/2021 | S · Sale | −10.71K | $12.53 | $134.26K | 0.3% | 3.97M | 3.96M |
| Total | −48.61K | -$624.18K | ||||||
Derivative Transactions0
No derivative transactions reported